New concepts concerning the clinical control of IgE synthesis.
Prospects for new therapeutic approaches to IgE-mediated allergic diseases have arisen from (1) recent experimental observations that have suggested new concepts concerning the pathogenesis of the allergic phenotype, and (2) adaptation of previously described methods for induction of specific immunological tolerance to problems to allergy. The bases for these new approaches to allergic diseases are summarized herein.
D000818:Animals; D001202:Ascitic Fluid / Q000276:immunology; D000939:Epitopes; D006967:Hypersensitivity / Q000276:immunology* / Q000378:metabolism / Q000628:therapy; D007108:Immune Tolerance; D007073:Immunoglobulin E / Q000096:biosynthesis / Q000276:immunology*; D007167:Immunotherapy; D051379:Mice; D008815:Mice, Inbred Strains; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D013997:Time Factors
D000939:Epitopes; D007073:Immunoglobulin E